Depression affects nearly 350 million people worldwide and is a leading cause of disability.(1)
healtheo360 Wellness Blog
Cutaneous T-Cell Lymphoma (CTCL) is a type of lymphoma, or cancer of the immune cells, that arises in T-cells in the skin (primarily). T-cells are an integral part of the immune system, helping to recognize and fight against viruses, bacteria, and even other types of cancers. CTCL is a rare form of non-Hodgkin lymphoma and is most common in the skin, but may affect the blood, lymph nodes, and other internal organs as well. This disease affects men more often than women, and usually occurs between the ages of 40 and 70. There are many forms of treatment that are used to slow the progression of CTCL, but none that serve as curative. Recently, however, there have been a number of emerging biologic and targeted therapies that can have impressive success with treating CTCL. This article will focus on the diagnosis/treatment planning of CTCL as well as describe several widely used treatments for CTCL.
Since cancer immunotherapy is an emerging class of treatment, many people find themselves poorly informed on the subject. Despite this, immunotherapy is poised to become the most powerful and widely used form of cancer treatment in the years to come. Already, immunotherapy is recognized by healthcare professionals as the most promising new cancer treatment approach since the production of the first chemotherapies back in the 1940s. Many professionals project that as more research is conducted, more and more immunotherapy treatments will be approved to treat more and more types of cancer. This research is dependent on the use of clinical trials, meaning the only way to get more immunotherapy treatments approved is through the cooperation of cancer patients, doctors, and scientists. Here, we will explore the potential of immunotherapy as a treatment for most (if not all) cancers, as well as discuss the importance of clinical trials to patients and scientists alike.
More than 15 million American adults are affected by depression annually, with the expectation that 16-20 out of 100 people will have the disorder at least once in their lives.(1)
Immunotherapy can be a complicated form of treatment. This guide is designed to explain the basics of a few of the most common types of immunotherapy treatments.
Parkinson’s disease affects 50% more men than it does women, with over 1 million total patients in the United States. (1)
Memory screening is the best way to spot potential problems with your thinking and memory. For older individuals, it is recommended if any changes in memory or cognition are noticed. Check out this infographic to learn more about memory screening and its increasing importance as we age.